Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

LifeCell Dx Founder Reports Marijuana Use Can Impact Ability to Have a Baby
  • USA - English


News provided by

LifeCell Dx

Jun 10, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

LifeCell Dx Performs Advanced Semen Analysis From Anywhere in the World Using the Internet and Digital Video
LifeCell Dx Performs Advanced Semen Analysis From Anywhere in the World Using the Internet and Digital Video

Buffalo, New York (PRWEB) June 10, 2014 -- LifeCell Dx’s founder, Chief Science Officer and Andrologist, Dr. Lani Burkman warns that the use of marijuana can impact fertility – the ability to produce a baby. Dr. Burkman is an internationally recognized expert on human fertilization and marijuana, with more than 25 years of clinical research.

"The enormous attention being given to legalizing marijuana for open use is of grave concern to me." - Dr. Lani Burkman, LifeCell Dx

Post this

“Our body naturally makes two kinds of cannabinoid chemicals that look like the marijuana ones. By using marijuana, the man or woman is putting the natural cannabinoid regulation out of balance, which can impact sperm and eggs, and many critical parts of one’s physiology. The increased use of marijuana in the United States is a contributing factor to the rise of infertility. Up to 7 million couples are struggling to create a family, and pointing the finger at each other saying, ‘Is it you or is it me?’ The enormous attention being given to legalizing marijuana for open use is of grave concern to me,” stated Dr. Burkman of LifeCell Dx.

LifeCell Dx is an e-fertility diagnostics laboratory in which patients can see the swimming sperm for themselves and be introduced to the answers that Burkman’s Advanced Semen Analysis will provide. The basic semen analysis available at most labs and infertility clinics is focused on sperm count and percent moving, but this cannot predict his actual fertility.

Advanced Semen Analysis gives the sperm count, but also quickly reveals whether his sperm are functioning like fertile sperm. Marijuana-exposed sperm typically function differently. Respecting all confidentiality, every patient is asked about his/her marijuana use, among other critical fertility-related questions.

“Couples deserve accurate information about sperm function since blind decision-making is very stressful on the relationship and personal finances. It is critical for patients to understand that endocannabinoids are responsible for helping certain processes run normally, or even block other systemic activities. The best-known endocannabinoids are called AEA (anandamide) and 2-AG (2-arachidonoylglycerol), but there are others as well. ‘Endo’ means inside our body; using external marijuana chemicals that mimic our natural “regulators” can produce effects almost anywhere in the body, whether on sperm, eggs, testis, uterus, heart, or central nervous system, etc.” Dr. Burkman emphasized.

Data from the National Institute on Drug Abuse indicate that marijuana is the most common illicit drug used in the United States (http://www.drugabuse.gov). After a period of decline in the last decade, its use has been increasing among young people since 2007.

“The risks are before, during and after, and couples deserve to have the truth, not the hype complicated by issues around de-criminalization. Even if they quit marijuana use, cannabinoids remain in the body for many months. Whether young and somewhat older, they need to hear that marijuana use changes sperm swimming patterns, attachment to the living egg, semen volume, total number of sperm in the sample, and cannabinoid levels found in the female’s reproductive organs. We are very good at predicting his fertilizing potential, as shown in our recent data presented at the national fertility meeting, American Society for Reproductive Medicine. Our Advanced Semen Analysis represents 20 years of clinical work with thousands of sperm tests. Couples should also know that we can serve patients living anywhere in the world through LifeCell Dx’s patented remote digital analysis process: the doctor sends sperm through the Internet to our central lab in Buffalo,” Dr. Burkman added.

The World Health Organization in Geneva brought some clarity when it defined infertility as an actual disease. According to the U.S. 2002 National Survey of Family Growth by the CDC, infertility affects about 12 percent of the reproductive-age population. In the United States, this includes 7.3 million women and their partners.

“We are here to help couples by giving them scientifically-sound information about their infertility and answers for the male through Advanced Semen Analysis at LifeCell Dx,” stated Dr. Burkman.

LifeCell Dx is located in Buffalo, New York. More information is available at http://www.lifecelldx.com. Dr. Lani Burkman may be reached at (716) 408-3306 or lburkman(at)lifecelldx(dot)com.

###

For Interviews
Dr. Lani Burkman
Cell: (716) 553-8353

Dr. Lani Burkman, Founder, LifeCell Dx, http://www.lifecelldx.com, +1 716 553-8353, [email protected]

Modal title

LifeCell Dx
LifeCell Dx
LifeCell Dx

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.